Company News: Curetis Announces Participation in Major Investor and Scientific Conferences in the Second Quarter 2017

Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis”), a developer of next-level molecular diagnostic solutions, today announced that the Company will attend several major industry conferences in the second quarter of 2017. The respective presentations will be made available on the company’s website.


10th Kempen Life Science Day, April 19, 2017 – Amsterdam, The Netherlands: company presentation and one-on-one meetings.

27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 22-25, 2017 – Vienna, Austria: exhibition booth in Hall B, booth 20; sponsored symposium “Detect to cure – superbugs in various healthcare settings. Diagnostic approaches to win the challenge”, Saturday, April 22, 01:30pm CET, Hall E.


ATS International Conference, May 19-24, 2017 – Washington DC, USA: exhibition booth 1206 and KOL meetings.

Donau Invest GmbH / Advantage Strategy & Finance – Family Office Pharma & Biotech Day, May 31, 2017 – Vienna, Austria: company presentation and Q&A session.


ASM Microbe 2017, June 1-5, 2017 – New Orleans, LA, USA: exhibition booth 2941 and oral presentation of Unyvero LRT clinical trial data.

goetzpartners Healthcare Day, June 29, 2017 – London, UK: one-on-one meetings and panel discussion.